Clinical Trial Update: Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) [Phase 4]

View source ↗

Summary

Clinical trial update noting the completion of a Phase 4 study evaluating the combination of ciclesonide nasal spray and azelastine nasal spray for perennial al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Azelastine nasal spray (azelastine)
• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Rhinitis, Allergic, Perennial | Phase 4 | Status: COMPLETED